Spinal muscular atrophy

E Mercuri, CJ Sumner, F Muntoni, BT Darras… - Nature Reviews …, 2022 - nature.com
Spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in
SMN1 (encoding survival motor neuron protein (SMN)). Reduced expression of SMN leads …

New treatments in spinal muscular atrophy: positive results and new challenges

S Messina, M Sframeli - Journal of clinical medicine, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases
with progressive weakness of skeletal and respiratory muscles, leading to significant …

Single-dose gene-replacement therapy for spinal muscular atrophy

JR Mendell, S Al-Zaidy, R Shell… - … England Journal of …, 2017 - Mass Medical Soc
Background Spinal muscular atrophy type 1 (SMA1) is a progressive, monogenic motor
neuron disease with an onset during infancy that results in failure to achieve motor …

[HTML][HTML] Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ …

RS Finkel, E Mercuri, OH Meyer, AK Simonds… - Neuromuscular …, 2018 - Elsevier
This is the second half of a two-part document updating the standard of care
recommendations for spinal muscular atrophy published in 2007. This part includes updated …

Spinal muscular atrophy: in the challenge lies a solution

B Wirth - Trends in neurosciences, 2021 - cell.com
The path from gene discovery to therapy in spinal muscular atrophy (SMA) has been a
highly challenging endeavor, but also led to one of the most successful stories in …

Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine

H Chaytow, KME Faller, YT Huang… - Cell Reports Medicine, 2021 - cell.com
Spinal muscular atrophy (SMA) is a devastating childhood motor neuron disease that, in the
most severe cases and when left untreated, leads to death within the first two years of life …

Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next

B Wirth, M Karakaya, MJ Kye… - Annual review of …, 2020 - annualreviews.org
Twenty-five years ago, the underlying genetic cause for one of the most common and
devastating inherited diseases in humans, spinal muscular atrophy (SMA), was identified …

Spinal muscular atrophy: diagnosis and management in a new therapeutic era

WD Arnold, D Kassar, JT Kissel - Muscle & nerve, 2015 - Wiley Online Library
Spinal muscular atrophy (SMA) describes a group of disorders associated with spinal motor
neuron loss. In this review we provide an update regarding the most common form of SMA …

Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting

SL Eaton, SL Roche, M Llavero Hurtado, KJ Oldknow… - PloS one, 2013 - journals.plos.org
Western blotting has been a key technique for determining the relative expression of
proteins within complex biological samples since the first publications in 1979. Recent …

Emerging therapies and challenges in spinal muscular atrophy

MA Farrar, SB Park, S Vucic, KA Carey… - Annals of …, 2017 - Wiley Online Library
Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disease with severity
ranging from progressive infantile paralysis and premature death (type I) to limited motor …